PMID- 22389081 OWN - NLM STAT- MEDLINE DCOM- 20120626 LR - 20131121 IS - 1099-1077 (Electronic) IS - 0885-6222 (Linking) VI - 27 IP - 2 DP - 2012 Mar TI - The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA. PG - 167-76 LID - 10.1002/hup.1261 [doi] AB - BACKGROUND: Cannabis and 3,4-methylenedioxymethamphetamine (MDMA) use is associated with psychobiological and neurocognitive deficits. Assessments of the latter typically include tests of memory and everyday cognitive functioning. However, to date, little attention has been paid to effects of drug use on psychological stress reactivity. We report three studies examining the effects of recreational use of cannabis and MDMA on mood and psychological responses to multitasking using a cognitively demanding laboratory stressor that provides an analogue for everyday situations involving responses to multiple stimuli. METHODS: The effects of the multitasking framework on mood and perceived workload were assessed in cannabis (N=25), younger (N=18) and older (N=20) MDMA users and compared with non-target drug controls. RESULTS: Compared with respective control groups, cannabis users became less alert and content, and both MDMA groups became less calm following acute stress. Unexpectedly, the stressor increased ratings of calm in cannabis users. Users also scored higher than their controls with respect to ratings of resources needed to complete the multitasking framework. CONCLUSIONS: These findings show, for the first time, that recreational use of cannabis and MDMA, beyond the period of intoxication, can negatively influence psychological responses to a multitasking stressor, and this may have implications for real-life situations which place high demands on cognitive resources. CI - Copyright (c) 2012 John Wiley & Sons, Ltd. FAU - Wetherell, Mark A AU - Wetherell MA AD - Health in Action: Stress Research Group, Department of Psychology, School of Life Sciences, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK. mark.wetherell@northumbria.ac.uk FAU - Atherton, Katie AU - Atherton K FAU - Grainger, Jessica AU - Grainger J FAU - Brosnan, Robert AU - Brosnan R FAU - Scholey, Andrew B AU - Scholey AB LA - eng PT - Journal Article PL - England TA - Hum Psychopharmacol JT - Human psychopharmacology JID - 8702539 RN - 0 (Hallucinogens) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adult MH - Affect/drug effects MH - Age Factors MH - Cannabis/chemistry MH - Female MH - Hallucinogens/*adverse effects MH - Humans MH - Male MH - Marijuana Abuse/*physiopathology/psychology MH - N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects MH - Neuropsychological Tests MH - Stress, Psychological/*etiology MH - Substance-Related Disorders/physiopathology MH - Workload/psychology MH - Young Adult EDAT- 2012/03/06 06:00 MHDA- 2012/06/27 06:00 CRDT- 2012/03/06 06:00 PHST- 2012/03/06 06:00 [entrez] PHST- 2012/03/06 06:00 [pubmed] PHST- 2012/06/27 06:00 [medline] AID - 10.1002/hup.1261 [doi] PST - ppublish SO - Hum Psychopharmacol. 2012 Mar;27(2):167-76. doi: 10.1002/hup.1261.